Clinical Trials in Denver

Showing 11521-11540 of 15,604 trials

Views of Cancer Patients Regarding Financial Conflicts of Interest

NCT00097682

This study will explore what research patients understand about financial collaborations in the research setting and their concerns about these collaborations. Financial partnerships are crucial to advancing medical research; however, they are giving rise to increasing concerns about financial conflicts of interest and possible impacts on the integrity of research and patient safety. This study will examine patients' views about financial ties between drug companies and the doctors running research studies, as well as ties between the drug companies and the cancer centers where the studies are conducted. Patients 18 years of age and older who are enrolled in cancer studies at the National Cancer Institute in Bethesda, MD; the Fred Hutchinson Cancer Research Center in Seattle, WA; the Dana-Farber Cancer Institute in Boston, MA; the Columbia Comprehensive University Herbert Irving Cancer Center in New York, NY; and the University of Colorado Cancer Center in Denver, CO, may be eligible for this study. Participants are interviewed about the following: * Patients' awareness and understanding about individual and institutional financial conflicts of interest, and how such conflicts, if they exist, are being managed * The impact of a researcher's financial ties on the patient's decision to participate in that researcher's study * The impact of the institution's financial ties on the patient's decision to participate in research at that institution * Attitudes about policies and practices regarding conflicts of interest in the research setting * Attitudes about disclosure of conflicts of interest in the research setting * Patient symptoms and performance * Patient's cancer trial * Patient's cancer history * Patient's trust * Patient demographics (gender, age, race, religion, education, income, health insurance, employment).

Neoplasms

National Institutes of Health Clinical Center (CC)300 participantsStarted Nov 2004

Denver, Colorado, United States • New Haven, Connecticut, United States • Boston, Massachusetts, United States +2 more locations

COMPLETEDPhase 2< 1 mile

Study of Voreloxin (Vosaroxin) in Older Patients With Untreated Acute Myeloid Leukemia

NCT00607997

This study will evaluate the overall remission rate of treatment with vosaroxin (formerly voreloxin) Injection in patients at least 60 years of age with previously untreated AML

LeukemiaAcute DiseaseAcute Myeloid Leukemia+2 more

Sunesis Pharmaceuticals113 participantsStarted May 2008

Phoenix, Arizona, United States • Scottsdale, Arizona, United States • La Jolla, California, United States +17 more locations

Views of Cancer Patients Regarding Financial Conflicts of Interest

Study of Voreloxin (Vosaroxin) in Older Patients With Untreated Acute Myeloid Leukemia

Find Trials by Condition in Denver

Evolution® Biliary Stent System-Fully Covered

Effect of Antacids on the Pharmacokinetics of Raltegravir

Chronic Dosing Cross-Over Study to Assess the Efficacy and Safety of Glycopyrronium (PT001) in Adult Subjects With Intermittent Asthma or Mild to Moderate Persistent Asthma

Study to Compare Safety and Efficacy of HX575 Epoetin Alfa and US-licensed Epoetin Alfa

Weaning And Variability Evaluation

Efficacy And Safety Of Tofacitinib In Psoriatic Arthritis: Comparator Study

Characterization of Childhood-Onset Obsessive-Compulsive Disorder

Evaluation of Sarilumab (SAR153191/REGN88) on Top of Methotrexate in Rheumatoid Arthritis Patients

A First Time in Human Study to Assess the Safety, Tolerability, Pharmacokinetics, and Antiviral Activity of Single and Repeat Doses of GSK2485852 in Chronically Infected Hepatitis C Subjects

A First Time in Human Study to Assess GSK2336805 in Healthy Volunteers and Single Doses in Chronically Infected Hepatitis C Patients.

Veliparib and Temozolomide in Treating Patients With Recurrent Glioblastoma

A Study of RO5186582 in Down Syndrome Among Children 6 to 11 Years of Age

Cetuximab + / - Carboplatin for Estrogen Receptor-Negative, Progesterone Receptor-Negative Metastatic Breast Cancer

H7N9 Mix and Match With MF59 in Healthy Elderly Persons

To Study Generic Clindamycin 1%/Benzoyl Peroxide 5% Topical Gel (Glenmark Generics, Ltd) in the Treatment of Acne Vulgaris.

A Short and Long Intravenous Infusion Study to Evaluate the Safety, Pharmacokinetics, and Pharmacodynamics of BMS-962212 in Healthy Subjects

Impact of a Human Papilloma Virus (HPV) Vaccine in HIV-Infected Young Women

Study of Adult T-Cell Leukemia/Lymphoma Among Carriers of HTLV-1